ArticleClinical and public health guidelines2026
A Guide for the Inclusion of Sex and Gender Considerations in Clinical Practice Guidelines.
Article in Clinical and public health guidelines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Guide for the Inclusion of Sex and Gender Considerations in Clinical Practice Guidelines.Clinical and public health guidelines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite increasing understanding of sex and gender as important determinants of health, there has been a lack of consideration regarding sex, gender, and other intersectional factors in clinical practice guidelines (CPGs) to date, and little support for guideline developers to address these shortcomings. The development of a guide for guideline developers to facilitate the systematic uptake of sex and gender considerations may enhance the uptake and consistency of sex and gender considerations in CPGs. Informed by a comprehensive programme of work that included an umbrella review of the global literature, extensive expert consultation and input from individuals with living experience, the resultant guide provides practical step-by-step strategies for CPG developers to systematically integrate sex and gender considerations throughout the guideline development process. Aligning with key global guideline development steps, this guide addresses an important clinical need to translate sex and gender-specific evidence into tailored clinical action, where relevant, and provides recommended pathways to improve guideline quality and equity. The integration of sex and gender into CPGs is a global imperative, and whilst acknowledging that guidelines are developed and disseminated differently across different countries and contexts, this guide has international relevance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.